Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
ESMO Open ; 9(2): 102234, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38281325

ABSTRACT

BACKGROUND: With increasing survival rates of adolescents and young adults (AYAs) with breast cancer, health-related quality of life (HRQoL) becomes more important. An important aspect of HRQoL is sexual QoL. This study examined long-term sexual QoL of AYA breast cancer survivors, compared sexual QoL scores with that of other AYA cancer survivors, and identified factors associated with long-term sexual QoL of AYA breast cancer survivors. MATERIALS AND METHODS: Data of the SURVAYA study were utilized for secondary analyses. Sexual QoL was assessed using the European Organization for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire (EORTC QLQ-SURV100). Descriptive statistics were used to describe sexual QoL of AYA cancer survivors. Linear regression models were constructed to examine the effect of cancer type on sexual QoL and to identify factors associated with sexual QoL. RESULTS: Of the 4010 AYA cancer survivors, 944 had breast cancer. Mean sexual QoL scores of AYA breast cancer survivors ranged from 34.5 to 60.0 for functional domains and from 25.2 to 41.5 for symptom-orientated domains. AYA breast cancer survivors reported significantly lower sexual QoL compared to AYA survivors of other cancer types on all domains. Age, time since diagnosis, relationship status, educational level, chemotherapy, hormonal therapy, breast surgery, body image, and coping were associated with sexual QoL of AYA breast cancer survivors. CONCLUSIONS: AYA breast cancer survivors experience decreased sexual QoL in the long term (5-20 years) after diagnosis and worse score compared to AYA survivors of other cancer types, indicating a clear need to invest in supportive care interventions for those at risk, to enhance sexual well-being.


Subject(s)
Breast Neoplasms , Cancer Survivors , Humans , Adolescent , Young Adult , Female , Breast Neoplasms/therapy , Quality of Life , Survivors , Breast
2.
ESMO Open ; 7(3): 100476, 2022 06.
Article in English | MEDLINE | ID: mdl-35533426

ABSTRACT

BACKGROUND: Adolescents and young adults (AYAs, aged 18-39 years) with advanced cancer have an increased life expectancy due to improvements and refinements in cancer therapies, resulting in a growing group of AYAs living with an uncertain and/or poor cancer prognosis (UPCP). To date, no studies have examined the difficulties of health care professionals (HCPs) providing care to AYAs with a UPCP. This study aimed to understand the challenges in daily clinical practice experienced by HCPs from different disciplines who provide palliative as well as general care to AYAs with a UPCP. METHODS: HCPs from a variety of backgrounds (e.g. clinical nurse specialists, medical oncologists, neurologists psychologists) were invited for a semi-structured interview. The interviews were transcribed verbatim and analysed using reflexive thematic analysis. Two AYA patients were actively involved as research partners to increase the relevance of the study design and to optimise interpretation of results. RESULTS: Forty-nine HCPs were interviewed. Overall, we found that the threat of premature death within this young patient group increased emotional impact on HCPs and evoked a feeling of unfairness, which was an extra motivation for HCPs to provide the most optimal care possible. We generated four key themes: (i) emotional confrontation (e.g. feeling helplessness and experiencing a greater sense of empathy), (ii) questioning own professional attitude and skills, (iii) navigating uncertainty (e.g. discussing prognosis and end of life) and (iv) obstacles in the health care organisation (e.g. lack of knowledge and clarity about responsibilities). CONCLUSIONS: HCPs experienced unique emotional and practical challenges when providing care to AYAs with a UPCP. The results from this study highlight the need to develop an education module for HCPs treating AYAs with UPCP to increase their own well-being and optimise the delivery of person- and age-adjusted care.


Subject(s)
Health Personnel , Neoplasms , Adolescent , Health Personnel/psychology , Humans , Neoplasms/therapy , Prognosis , Uncertainty , Young Adult
3.
Eur Heart J ; 39(48): 4269-4276, 2018 12 21.
Article in English | MEDLINE | ID: mdl-30551207

ABSTRACT

Aims: We sought to determine subtypes of patients with heart failure (HF) with a distinct clinical profile and treatment response, using a wide range of biomarkers from various pathophysiological domains. Methods and results: We performed unsupervised cluster analysis using 92 established cardiovascular biomarkers to identify mutually exclusive subgroups (endotypes) of 1802 patients with HF and reduced ejection fraction (HFrEF) from the BIOSTAT-CHF project. We validated our findings in an independent cohort of 813 patients. Based on their biomarker profile, six endotypes were identified. Patients with endotype 1 were youngest, less symptomatic, had the lowest N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and lowest risk for all-cause mortality or hospitalization for HF. Patients with endotype 4 had more severe symptoms and signs of HF, higher NT-proBNP levels and were at highest risk for all-cause mortality or hospitalization for HF [hazard ratio (HR) 1.4; 95% confidence interval (CI) 1.1-1.8]. Patients with endotypes 2, 3, and 5 were better uptitrated to target doses of beta-blockers (P < 0.02 for all). In contrast to other endotypes, patients with endotype 5 derived no potential survival benefit from uptitration of angiotensin-converting enzyme-inhibitor/angiotensin-II receptor blocker and beta-blockers (Pinteraction <0.001). Patients with endotype 2 (HR 1.29; 95% CI 1.10-1.42) experienced possible harm from uptitration of beta-blockers in contrast to patients with endotype 4 and 6 that experienced benefit (Pinteraction for all <0.001). Results were strikingly similar in the independent validation cohort. Conclusion: Using unsupervised cluster analysis, solely based on biomarker profiles, six distinct endotypes were identified with remarkable differences in characteristics, clinical outcome, and response to uptitration of guideline directed medical therapy.


Subject(s)
Biomarkers/blood , Heart Failure/drug therapy , Natriuretic Peptide, Brain/metabolism , Peptide Fragments/metabolism , Stroke Volume/drug effects , Adrenergic beta-Antagonists/therapeutic use , Aged , Aged, 80 and over , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Cluster Analysis , Female , Heart Failure/epidemiology , Heart Failure/mortality , Heart Failure/physiopathology , Hospitalization , Humans , Male , Middle Aged , Natriuretic Peptide, Brain/drug effects , Peptide Fragments/drug effects , Phenotype , Practice Guidelines as Topic , Treatment Outcome
5.
Cell Death Dis ; 4: e782, 2013 Aug 29.
Article in English | MEDLINE | ID: mdl-23990022

ABSTRACT

In the lymph node (LN) environment, chronic lymphocytic leukemia (CLL) cells display increased NF-κB activity compared with peripheral blood CLL cells, which contributes to chemoresistance. Antagonists of cellular inhibitor of apoptosis proteins (cIAPs) can induce apoptosis in various cancer cells in a tumor necrosis factor-α (TNFα)-dependent manner and are in preclinical development. Smac-mimetics promote degradation of cIAP1 and cIAP2, which results in TNFR-mediated apoptosis via formation of a ripoptosome complex, comprising RIPK1, Fas-associated protein with death domain, FLICE-like inhibitory protein and caspase-8. CD40 stimulation of CLL cells in vitro is used as a model to mimic the LN microenvironment and results in NF-κB activation and TNFα production. In this study, we investigated the response of CLL cells to smac-mimetics in the context of CD40 stimulation. We found that treatment with smac-mimetics results in cIAP1 and cIAP2 degradation, yet although TNFα is produced, this did not induce apoptosis. Despite the presence of all components, the ripoptosome complex did not form upon smac-mimetic treatment in CLL cells. Thus, CLL cells seem to possess aberrant upstream NF-κB regulation that prevents ripoptosome formation upon IAP degradation. Unraveling the exact molecular mechanisms of disturbed ripoptosome formation may offer novel targets for treatment in CLL.


Subject(s)
Drug Resistance, Neoplasm , Intracellular Signaling Peptides and Proteins/metabolism , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Multiprotein Complexes/metabolism , 3T3 Cells , Animals , Baculoviral IAP Repeat-Containing 3 Protein , Biphenyl Compounds/pharmacology , CD40 Antigens/metabolism , CD40 Ligand/metabolism , Cell Death/drug effects , Drug Resistance, Neoplasm/drug effects , Drug Resistance, Neoplasm/genetics , Gene Expression Regulation, Neoplastic/drug effects , Humans , Inhibitor of Apoptosis Proteins/metabolism , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Mice , Mutation/genetics , NF-kappa B/metabolism , Nitrophenols/pharmacology , Piperazines/pharmacology , Proteasome Endopeptidase Complex/metabolism , Proteolysis/drug effects , Receptors, Tumor Necrosis Factor, Type I/metabolism , Receptors, Tumor Necrosis Factor, Type II/metabolism , Signal Transduction/drug effects , Signal Transduction/genetics , Sulfonamides/pharmacology , Tumor Necrosis Factor-alpha/biosynthesis , Ubiquitin-Protein Ligases
6.
Oncogene ; 29(36): 5071-82, 2010 Sep 09.
Article in English | MEDLINE | ID: mdl-20581863

ABSTRACT

Chronic lymphocytic leukemia (CLL) cells circulating in peripheral blood (PB) differ from the leukemic fraction in lymph nodes (LNs) with respect to cell division and drug sensitivity. CD40 stimulation of PB CLL cells in vitro results in chemoresistance and provides a partial model for the LN microenvironment. The TLR9 ligand CpG induces proliferation in immunoglobulin variable heavy-chain-unmutated CLL, but apoptosis in immunoglobulin variable heavy-chain-mutated CLL. To juxtapose proliferative with antiapoptotic signals, we investigated the effects of CpG in the context of CD40 ligation in mutated versus unmutated CLL cells in this study. Prolonged CD40 ligation induced classical, followed by alternative nuclear factor-kappaB (NF-kappaB), activity in both subgroups, correlating with enhanced Bfl-1 and Bcl-X(L) levels, respectively. A dichotomy in NF-kappaB signaling occurred on combined CD40/TLR9 triggering. This induced declining p52 and Bcl-X(L) levels, and reversed chemoresistance only in mutated cells, whereas unmutated cells proliferated, maintained p52 and Bcl-X(L) and remained chemoresistant. The pivotal contribution of Bcl-X(L) to chemoresistance was shown by the BH3 mimetic ABT-737 and RNA interference. Finally, in ex vivo LN samples, p52, p65 and Bcl-X(L) levels were highly expressed, corroborating the in vitro findings. Thus, a distinction in NF-kappaB activation and drug susceptibility in mutated versus unmutated (LN-like) CLL cells was uncovered, which was causally linked to Bcl-X(L) levels.


Subject(s)
CD40 Antigens/agonists , Drug Resistance, Neoplasm , Immunoglobulin Heavy Chains/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , NF-kappa B/physiology , Toll-Like Receptor 9/agonists , Animals , Biphenyl Compounds/pharmacology , CD40 Antigens/metabolism , CD40 Ligand/metabolism , CD40 Ligand/pharmacology , Cell Proliferation/drug effects , Cells, Cultured , Drug Resistance, Neoplasm/drug effects , Drug Resistance, Neoplasm/genetics , Humans , Immunoglobulin Variable Region/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Lymphocyte Activation/drug effects , Mice , Mutation/physiology , NIH 3T3 Cells , Nitrophenols/pharmacology , Oligodeoxyribonucleotides/pharmacology , Piperazines/pharmacology , Signal Transduction/drug effects , Signal Transduction/physiology , Sulfonamides/pharmacology , Toll-Like Receptor 9/metabolism , bcl-X Protein/metabolism , bcl-X Protein/physiology
7.
Am J Transplant ; 6(1): 121-8, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16433766

ABSTRACT

Studies of renal transplantation utilizing trough plasma level monitoring of mycophenolic acid (MPA) have shown inconsistent associations with toxicity and rejection. In this study, 5600 12-h trough MPA samples from 121 renal transplant recipients immunosuppressed with mycophenolate mofetil (MMF) and tacrolimus in a steroid sparing protocol (steroids for 7 days only) were sequentially analyzed. Higher MPA levels were associated with lower hemoglobin concentrations and anemia (hemoglobin <10 g/dL). Similarly, higher MPA levels were associated with lower total white cell counts and an increased incidence of leucopenia (total white cell count <4.0 x 10(9)/L). Hypoalbuminemia and renal impairment were also associated with hemotoxicity. MMF-associated diarrhea and viral infection were associated with higher MPA levels. Conversely, biopsy-proven acute rejection within the first month post-transplantation was associated with lower MPA levels. Anti-CD25 antibody induction was also associated with reduced rejection rates. No association was seen between MPA levels and platelet count, thrombocytopenia or bacterial infection. An MPA level of 1.60 mg/L early post-transplantation best discriminated patients with and without rejection, and an MPA level of 2.75 mg/L best discriminated patients with and without toxicity later post-transplantation.


Subject(s)
Graft Rejection/diagnosis , Immunosuppressive Agents/blood , Kidney Transplantation , Mycophenolic Acid/blood , Adult , Bacterial Infections/diagnosis , Bone Marrow/immunology , Diarrhea/diagnosis , Dose-Response Relationship, Drug , Drug Monitoring , Female , Humans , Immunosuppression Therapy , Immunosuppressive Agents/adverse effects , Leukocyte Count , Leukopenia/diagnosis , Male , Middle Aged , Monitoring, Physiologic , Mycophenolic Acid/adverse effects , Platelet Count , Tacrolimus/blood , Thrombocytopenia/diagnosis , Virus Diseases/diagnosis
8.
Transplant Proc ; 37(4): 1733-5, 2005 May.
Article in English | MEDLINE | ID: mdl-15919448

ABSTRACT

It is recommended that specific methods of tacrolimus monitoring rather than immunoassays, which overestimate tacrolimus levels, should be used in transplant recipients. Direct comparison of these techniques, however, has not been conducted in renal transplantation. In this study, 40 renal transplant recipients with tacrolimus monitoring by microparticle enzyme immunoassay (MEIA; target trough level 10 to 15 ng/mL) were compared with 40 patients monitored by high-performance liquid chromatography with tandem mass spectrometry (HPLC-MS; target trough level 8 to 13 ng/mL). All patients received anti CD25 antibody induction and mycophenolate mofetil in a steroid-sparing protocol. No differences were seen between MEIA and HPLC-MS groups in patient demographics. All patients were followed for 6 months. Patient survival was 100% in both groups; graft survival was 100% in the MEIA group and 97.5% in the HPLC-MS group. The groups did not differ in the number of dose changes required in the first 6 months or in the number of patients displaying tacrolimus levels within target range at 3 and 6 months. Delayed graft function occurred in 14 patients in the MEIA group and 12 patients in the HPLC-MS group (P = NS). Biopsy-proven acute rejection occurred in four patients in the MEIA group and one patient in the HPLC-MS group (P < .2). No differences were seen for the following parameters at 3 or 6 months: biopsy-proven tacrolimus nephrotoxicity, serum creatinine or estimated creatinine clearance, systolic or diastolic blood pressure, cholesterol, cytomegalovirus disease, posttransplant diabetes, or tremor. This study suggests that renal transplantation with HPLC-MS monitoring of tacrolimus is safe and effective.


Subject(s)
Kidney Transplantation/immunology , Tacrolimus/pharmacokinetics , Blood Pressure , Chromatography, High Pressure Liquid/methods , Drug Monitoring/methods , Graft Rejection/epidemiology , Graft Survival , Humans , Immunoenzyme Techniques , Immunosuppressive Agents/pharmacokinetics , Kidney Transplantation/mortality , Mass Spectrometry , Survival Analysis
9.
Transplant Proc ; 37(4): 1792-4, 2005 May.
Article in English | MEDLINE | ID: mdl-15919468

ABSTRACT

Although renal transplantation with a 7-day steroid-sparing regimen, tacrolimus and mycophenolate, is associated with good short-term outcomes, late allograft dysfunction and failure remain concerns. In this study 101 consecutive patients underwent renal transplantation using this immunosuppressive regimen. In addition, anti-CD25 monoclonal antibody was used in 25 high-risk patients (regrafts, two-antigen human leukocyte antigen (HLA)-DR mismatch or sensitized with anti-HLA panel reactivity >30%). After a median follow-up of 39 months (range 29 to 49), overall patient survival is 98%, with two cardiac deaths. Three other graft losses occurred, one each to early venous thrombosis, polyoma viral nephropathy, and late rejection due to noncompliance. Therefore, overall graft survival is 95%. The acute rejection rate at 6 and 12 months was 19% (no rejection occurred between months 6 and 12). Late rejection was uncommon, with only two further episodes beyond 12 months. Mean creatinine at 12 months was 144 micromol/L and mean estimated glomerular filtration rate (GFR) of 55 mL/min. Graft function was stable at 3 years with a mean creatinine of 142 micromol/L and mean estimated GFR 56 mL/min. During the study, five patients developed posttransplant diabetes mellitus (two cases beyond 12 months). Tissue-invasive cytomegalovirus disease and BK viral nephropathy each occurred in three patients, with all episodes in the first 12 months. Mean weight gain is 3.3 kg and mean blood pressure is 135/81 on an average of 1.5 antihypertensive agents. This steroid-avoidance regimen is associated with excellent medium-term patient and graft outcomes and a low incidence of side effects.


Subject(s)
Glucocorticoids/adverse effects , Kidney Transplantation/physiology , Mycophenolic Acid/analogs & derivatives , Tacrolimus/therapeutic use , Antibodies, Monoclonal/therapeutic use , Creatinine/blood , Follow-Up Studies , Glomerular Filtration Rate , Graft Rejection/epidemiology , Graft Rejection/immunology , Graft Rejection/prevention & control , Graft Survival , Histocompatibility Testing , Humans , Kidney Transplantation/immunology , Kidney Transplantation/mortality , Mycophenolic Acid/therapeutic use , Reoperation , Survival Analysis , Time Factors , Treatment Outcome
10.
Tijdschr Diergeneeskd ; 130(24): 758-61, 2005 Dec 15.
Article in Dutch | MEDLINE | ID: mdl-16395959

ABSTRACT

During a farm visit a breeding bull was presented with signs of anorexia, somnolence, and loss of condition. These signs were chronic and slowly progressive. Clinical examination revealed an enlarged liver and subsequent ultrasonography revealed multiple abscesses in the liver. This was confirmed during post-mortem examination. Ultrasonography, proved to be of great diagnostic value, especially because it is a quick and non-invasive procedure.


Subject(s)
Cattle Diseases/diagnostic imaging , Liver Abscess/veterinary , Animals , Anorexia/etiology , Anorexia/veterinary , Cattle , Cattle Diseases/diagnosis , Cattle Diseases/pathology , Diagnosis, Differential , Fatal Outcome , Liver Abscess/diagnosis , Liver Abscess/diagnostic imaging , Liver Abscess/pathology , Male , Ultrasonography
11.
Transplantation ; 76(7): 1120-3, 2003 Oct 15.
Article in English | MEDLINE | ID: mdl-14557763

ABSTRACT

BACKGROUND: Acute rejection has been the major risk factor for medium-term kidney graft loss because of chronic allograft nephropathy. We investigated whether the use of improved immunosuppression has altered the relationship between acute and chronic rejection by analyzing data from 245 renal transplant patients receiving Tacrolimus-based immunosuppression. RESULTS: Five-year graft survival (censored for death with functioning graft) was 88.8% with no significant difference between living and cadaveric kidney transplants. The only significant predictor of medium-term graft loss was acute vascular rejection. CONCLUSION: Under Tacrolimus-based immunosuppression, the occurrence of acute interstitial rejection, even when occurring late, repeatedly, or with failure of graft function to return to baseline, was not associated with chronic allograft nephropathy or medium-term graft loss. Vascular rejection remains the major immunological obstacle to long-term transplant success. Five-year overall survival rates with a functioning graft of 80% with 90% graft survival censored for death with function seem to be realistic and achievable goals.


Subject(s)
Graft Rejection/epidemiology , Graft Rejection/physiopathology , Immunosuppressive Agents/therapeutic use , Kidney Transplantation , Kidney/blood supply , Tacrolimus/therapeutic use , Adult , Blood Vessels/physiopathology , Female , Graft Rejection/mortality , Graft Survival , Humans , Incidence , Male
12.
Science ; 285(5431): 1231-6, 1999 Aug 20.
Article in English | MEDLINE | ID: mdl-10455043

ABSTRACT

With the use of a large collection of free-oscillation data and additional constraints imposed by the free-air gravity anomaly, lateral variations in shear velocity, compressional velocity, and density within the mantle; dynamic topography on the free surface; and topography on the 660-km discontinuity and the core-mantle boundary were determined. The velocity models are consistent with existing models based on travel-time and waveform inversions. In the lowermost mantle, near the core-mantle boundary, denser than average material is found beneath regions of upwellings centered on the Pacific Ocean and Africa that are characterized by slow shear velocities. These anomalies suggest the existence of compositional heterogeneity near the core-mantle boundary.

13.
Ned Tijdschr Tandheelkd ; 105(6): 206-8, 1998 Jun.
Article in Dutch | MEDLINE | ID: mdl-11928140

ABSTRACT

OBJECTIVE: To evaluate the long-term results of traditional therapy consisting of initial preparation followed by mucogingival surgery including bone recontouring and regular maintenance treatments. DESIGN: 125 patients between 25 and 70 with a generalised periodontitis of the type adult and rapidly progressing periodontitis were selected. These patients were treated according to a fixed protocol by a periodontist and a dental hygienist. SETTING: The Practice for Periodontology in Groningen. METHODS: Patients were treated in a practice limited to periodontology. Before and 5 years after treatment the following data were assessed: plaque- and bleeding-score, probing pocket-depth, mobility and furcation involvement. Furthermore the reason for extraction was established. RESULTS: In general a great reduction in plaque- and bleeding-score and probing pocket-depth was much better in case of good oral hygiene. Within 5 years after treatment only 1.1% of the teeth were extracted. Furcations with through and through involvement in combination with deep residual pockets were mostly the reason for this. CONCLUSION: It is concluded that with traditional periodontal therapy following a strict protocol including regular maintenance treatments excellent treatment results can be achieved.


Subject(s)
Periodontal Diseases/therapy , Adult , Aged , Dental Plaque Index , Female , Humans , Male , Middle Aged , Oral Hygiene , Periodontal Index , Periodontal Pocket/diagnosis , Periodontitis/therapy , Time Factors , Tooth Extraction , Treatment Outcome
15.
Ned Tijdschr Tandheelkd ; 105(3): 91-3, 1998 Mar.
Article in Dutch | MEDLINE | ID: mdl-11928408

ABSTRACT

The system of maintenance determines the long term success of periodontal therapy. Guided tissue regeneration enables us to regenerate lost periodontal supporting tissues. Likewise a good maintenance system is very important. Since regeneration of periodontal tissue is a relatively slow process, the direct post-operative care differs somewhat from the traditional treatment. Prevention of infection and trauma is of the utmost importance.


Subject(s)
Bone Regeneration/physiology , Periodontal Diseases/surgery , Periodontics/methods , Guided Tissue Regeneration, Periodontal , Humans , Periodontal Diseases/therapy , Postoperative Care
16.
J Theor Biol ; 182(4): 463-7, 1996 Oct 21.
Article in English | MEDLINE | ID: mdl-8944893

ABSTRACT

We present some new results on a well-known distance measure between evolutionary trees. The trees we consider are free 3-trees having n leaves labeled 0,...,n - 1 (representing species), and n - 2 internal nodes of degree 3. The distance between two trees is the minimum number of nearest neighbour interchange (NNI) operations required to transform one into the other. First, we improve an upper bound on the nni-distance between two arbitrary n-node trees from 4n log n (Culik & Wood, 1982, Inf. Pro. Letts. 15, 39-42) to n log n. Second, we present a counterexample disproving several theorems in (Waterman & Smith, 1978, J. theor. Biol. 73, 789-800). Roughly speaking, finding an equal partition between two trees does not imply decomposability of the distance finding problem. Third, we present a polynomial-time approximation algorithm that, given two trees, finds a transformation between them of length O(log n) times their distance. We also present some results of computations we performed on small size trees.


Subject(s)
Algorithms , Biological Evolution , Computational Biology , Animals , Models, Biological
17.
Behav Processes ; 22(3): 151-5, 1991 Jan.
Article in English | MEDLINE | ID: mdl-24897175

ABSTRACT

An analysis of the relation between sleep postures and EEG power spectrum of young, adult and old male rats was performed. Three postures were distinguished: stretched, curved and curled up. A 5 minutes period of any posture was analyzed. The sleep data were gathered of the first two hours of the sleep period. The analysis revealed that the overall power of a curled up posture was less than that of two other sleep postures. Determination of a relation between an EEG measurement and sleep postures is promising.

18.
Community Dent Oral Epidemiol ; 17(2): 87-90, 1989 Apr.
Article in English | MEDLINE | ID: mdl-2920545

ABSTRACT

The purpose of this study was to assess the success of the dental hygienist in the dental health education of dental patients in general dental practice. Special emphasis was laid on health education in the field of periodontics. The answers on a questionnaire of 159 dental patients who visited a dental hygienist were compared with the answers of 302 dental patients who had never visited a dental hygienist. The comparison was done by means of t-test and regression analysis on specially developed scales with regard to knowledge, motivation, self-care, and perception of change. On all scales the dental patients who visited a dental hygienist scored better. This difference remained when social demographic variables and the dentist's influence were taken into account. This indicates that the dental hygienist is successful in the behavioral aspect of her work.


Subject(s)
Dental Hygienists , Health Behavior , Health Education, Dental , Motivation , Oral Hygiene , Professional-Patient Relations , Self Care , Adult , Dental Care , Dentist-Patient Relations , Female , Humans , Male , Periodontal Diseases
19.
Community Dent Oral Epidemiol ; 17(1): 11-3, 1989 Feb.
Article in English | MEDLINE | ID: mdl-2917455

ABSTRACT

The purpose of the study was to assess whether cooperation with a dental hygienist was based on pursuit of financial gain or on aspirations to improve patient care. To this end a questionnaire was sent to 972 dentists. 412 dentists replied, of whom 178 had patients treated by a dental hygienist. Questions were asked regarding practice profile, preventive orientation and dentists' opinion about the material and immaterial value of cooperation with a dental hygienist. Discriminant analysis showed that the main distinguishing factor between dentists who did and dentists who did not cooperate with dental hygienists was their opinion about the quality of the dental hygienists' work in relation to the non-financial costs for patients, insurance companies, and dentists. The difference in the dentists' opinions about the direct profitability of dental hygienists was not significant. The conclusion can be drawn that the orientation of Dutch dentists towards care for their patients plays a more important role in a dentist's decision to cooperate with a dental hygienist than is usually presumed.


Subject(s)
Attitude of Health Personnel , Cooperative Behavior , Dental Hygienists , Dentists , Interprofessional Relations , Dental Hygienists/psychology , Dentists/psychology , Financial Management , Humans , Oral Health , Patient Care Team , Periodontics , Practice Management, Dental/economics
20.
Br J Haematol ; 63(1): 35-46, 1986 May.
Article in English | MEDLINE | ID: mdl-2423110

ABSTRACT

A murine monoclonal IgM erythrocyte antibody appeared to have anti-P (anti-globoside) specificity. The antibody was a relatively weak cold agglutinin, but a strong haemolysin and its reactivity with red cells was markedly enhanced by enzyme treatment. This antibody was used to study the cell and tissue distribution of globoside. Globoside was not only detectable on red cells and erythroblasts, but also on endothelial cells and on subsets of platelets, megakaryocytes and fibroblasts. It was not detectable on granulocytes, monocytes and most peripheral blood lymphocytes. Neither was it present on erythroblast precursors (CFU-E, BFU-E), pro-erythroblasts or on the cells of the pro-erythroblastic cell lines K562 and HEL. However, K562 cells expressed globoside when induced to mature into erythroblasts by sodium butyrate. Cells of patients with various leukaemias were also tested. A significant number of positively reacting cells was frequently (six out of 18) seen in cases with a CML blast crisis (CML-BC) and rarely in AML (four out of 37 cases). In CML-BC the P-positive cells were probably erythroblasts and/or megakaryoblasts. Thus, globoside appeared to be an interesting marker in CML-BC of the erythroblastic or mixed erythroblastic-megakaryoblastic type.


Subject(s)
Antibodies, Monoclonal/immunology , Blood Group Antigens/immunology , Immunoglobulin M/immunology , P Blood-Group System/immunology , Animals , Colony-Forming Units Assay , Epitopes , Fluorescent Antibody Technique , Globosides/analysis , Humans , Leukemia/immunology , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...